Business Wire

$15M Global Learning XPRIZE Culminates With Two Grand Prize Winners

Share

Today, XPRIZE, the global leader in designing and operating incentive competitions to solve humanity’s grand challenges, announced two grand prize winners in the $15M Global Learning XPRIZE. The tie between Kitkit School, from South Korea and the United States, and onebillion, from Kenya and the United Kingdom, was revealed at an awards ceremony hosted at the Google Spruce Goose Hangar in Playa Vista, where supporters and benefactors including Elon Musk celebrated all five finalist teams for their efforts.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190515006101/en/

Emily Church, executive director of the Global Learning XPRIZE, Dr. Peter H. Diamandis, founder and  ...

Emily Church, executive director of the Global Learning XPRIZE, Dr. Peter H. Diamandis, founder and executive chairman of XPRIZE, Anousheh Ansari, CEO of XPRIZE, and Elon Musk, who provided XPRIZE with the $10M prize purse, present the two grand prize winning teams of the Global Learning XPRIZE, Kitkit School and onebillion, with a $5 million check, each (Courtesy Jesse Grant, Getty).

Launched in 2014, the Global Learning XPRIZE challenged innovators around the globe to develop scalable solutions that enable children to teach themselves basic reading, writing and arithmetic within 15 months. After being selected as finalists, five teams received $1M each and went on to field test their education technology solution in Swahili, reaching nearly 3,000 children across 170 villages in Tanzania. To help ensure anyone, anywhere can iterate, improve upon, and deploy the learning solutions in their own community, all five finalists’ software are open source. All five learning programs are currently available in both Swahili and English on GitHub, including instructions on how to localize into other languages.

The competition offered a $10 million grand prize to the team whose solution enabled the greatest proficiency gains in reading, writing and arithmetic in the field test. After reviewing the field test data, an independent panel of judges found indiscernible results between the top two performers, and determined two grand prize winners would split the prize purse, receiving $5M each:

  • Kitkit School (Berkeley, United States, and Seoul, South Korea) developed a learning program with a game-based core and flexible learning architecture aimed at helping children independently learn, irrespective of their knowledge, skill, and environment.
  • onebillion (London, United Kingdom, and Nairobi, Kenya) merged numeracy content with new literacy material to offer directed learning and creative activities alongside continuous monitoring to respond to different children’s needs.

Currently, more than 250 million children around the world cannot read or write, and according to data from the UNESCO Institute for Statistics, about one in every five children are out of school – a figure that has barely changed over the past five years. Compounding the issue is a massive shortage of teachers at the primary and secondary levels, with research showing that the world must recruit 68.8 million teachers to provide every child with primary and secondary education by 2030.

Before the Global Learning XPRIZE field test, 74% of the participating children were reported as never attending school, 80% reported as never being read to at home, and over 90% of participating children could not read a single world in Swahili. After 15 months of learning on Pixel C tablets donated by Google and preloaded with one of the five finalists’ learning software, that number was cut in half. Additionally, in math skills, all five software were equally as effective for girls and boys.

Collectively over the course of the competition, the five finalist teams invested approximately $200M in research, development, and testing for their software, a total that rises to nearly $300M when including all 198 registered teams.

“Education is a fundamental human right, and we are so proud of all the teams and their dedication and hard work to ensure every single child has the opportunity to take learning into their own hands,” said Anousheh Ansari, CEO of XPRIZE. “Learning how to read, write and demonstrate basic math are essential building blocks for those who want to live free from poverty and its limitations, and we believe that this competition clearly demonstrated the accelerated learning made possible through the educational applications developed by our teams, and ultimately hope that this movement spurs a revolution in education worldwide.”

The grand prize winners and the following finalist teams were chosen from a field of 198 teams from 40 countries:

  • CCI (New York, United States) developed structured and sequential instructional programs, in addition to a platform seeking to enable non-coders to develop engaging learning content in any language or subject area.
  • Chimple (Bangalore, India) created a learning platform aimed at enabling children to learn reading, writing and mathematics on a tablet through more than 60 explorative games and 70 different stories.
  • RoboTutor (Pittsburgh, United States) leveraged Carnegie Mellon’s research in reading and math tutors, speech recognition and synthesis, machine learning, educational data mining, cognitive psychology, and human-computer interaction.

“By making each software open source, the Global Learning XPRIZE and the finalist teams are providing an advanced tool that the world can build upon and adapt to needs of their specific community. We believe this is a major advancement for the global movement to transform how we can help to bring quality learning to children anywhere,” said Executive Director of the Global Learning XPRIZE Emily Church. “Children everywhere, whether they do not have access to school, have had intermittent access to a classroom, or want to supplement their current education, have the basic human right to learn.”

The Global Learning XPRIZE was made possible by the generosity and support of a consortium of benefactors, philanthropists and partners including the United Nations’ Educational, Scientific and Cultural Organization (UNESCO), the World Food Programme (WFP), and the Government of Tanzania.

Following the grand prize announcement, XPRIZE is working to secure and load the software onto tablets; localize the software into different languages; and deliver preloaded hardware and charging stations to remote locations so all finalist teams can scale their learning software across the world. The public is invited to sign the pledge to show their support and join the Global Learning XPRIZE community to help provide an education for all children, everywhere.

For more information, visit learning.xprize.org.

About XPRIZE

XPRIZE, a 501(c)(3) nonprofit, is the global leader in designing and implementing innovative competition models to solve the world’s grandest challenges. Active competitions include the $20M NRG COSIA Carbon XPRIZE, the $10M ANA Avatar XPRIZE, the $7M Shell Ocean Discovery XPRIZE, and the $5M IBM Watson AI XPRIZE. For more information, visit xprize.org.

Contact information

Eric Desatnik
310.741.4892
eric@xprize.org

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Approves OTEZLA® (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease19.7.2019 20:59:00 EESTPress release

Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has approved OTEZLA® (apremilast) 30 mg twice daily (BID) for the treatment of adult patients with oral ulcers associated with Behçet’s Disease. OTEZLA, an oral, selective inhibitor of phosphodiesterase 4 (PDE4), is the first and only approved treatment option for oral ulcers associated with Behçet’s Disease, a rare, chronic, multisystem inflammatory disease that is difficult to treat. “Oral ulcers are a recurring and debilitating manifestation that affects nearly everyone living with Behçet’s Disease, and have an important negative impact on the quality of life for these patients,” said Yusuf Yazici, M.D., Clinical Associate Professor, Department of Medicine, New York University Langone Health. “In the clinical trial, OTEZLA demonstrated improvements in measures of oral ulcers at week 12. OTEZLA has the potential to be a needed treatment option for U.S. patients and their physicians, who

Abiraterone Acetate Included in World Health Organisation’s Essential Medicines List for the Treatment of Metastatic Castration-Resistant Prostate Cancer19.7.2019 16:05:00 EESTPress release

The Janssen Pharmaceutical Companies of Johnson & Johnson is delighted with the recent announcement from the World Health Organisation (WHO) to include abiraterone acetate (ZYTIGA ® ) for the treatment of metastatic castration-resistant prostate cancer (mCRPC), in the updated Essential Medicines List, published on 9th July 2019.1,2 The WHO’s Essential Medicines List is a core guidance document that helps countries prioritise critical health products that are recommended to be widely available and affordable throughout health systems.1 “The inclusion of abiraterone acetate in the WHO Essential Medicines List highlights the critical role that this treatment can play in improving the lives of patients living with mCRPC and their families,” said Dr. Joaquín Casariego, Janssen Therapeutic Area Lead Oncology for Europe, Middle East & Africa, Janssen-Cilag S.A. “I am proud that we are working hard to impact survival and quality of life by developing and providing innovative medicines which ar

Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis19.7.2019 15:30:00 EESTPress release

Gilead Sciences, Inc. (NASDAQ: GILD) announced today that it has licensed three preclinical antiviral programs from Novartis, including investigational agents with the potential to treat human rhinovirus, influenza and herpes viruses. Under the agreement, Gilead will acquire exclusive global rights to develop and commercialize novel small molecules against three undisclosed targets. Novartis will receive an upfront payment and is eligible to receive up to an additional $291 million in potential milestone payments upon achievement of certain development and commercial milestones, as well as royalties on annual net sales. “Today’s announcement builds on Gilead’s heritage in antiviral research and development. We look forward to applying this expertise to advance the development of potential new treatments for viruses with limited therapeutic options,” said John McHutchison AO, MD, Gilead’s Chief Scientific Officer and Head of Research and Development. Gilead’s antiviral portfolio include

Schlumberger Announces Second-Quarter 2019 Results19.7.2019 14:00:00 EESTPress release

Schlumberger Limited (NYSE: SLB) today reported results for the second quarter of 2019. (Stated in millions, except per share amounts) Three Months Ended Change Jun. 30, 2019 Mar. 31, 2019 Jun. 30, 2018 Sequential Year-on-year Revenue $8,269 $7,879 $8,303 5% 0% Pretax segment operating income $968 $908 $1,094 7% -12% Pretax segment operating margin 11.7% 11.5% 13.2% 17 bps -148 bps Net income - GAAP basis $492 $421 $430 17% 14% Net income, excluding charges & credits* $492 $421 $594 17% -17% Diluted EPS - GAAP basis $0.35 $0.30 $0.31 17% 13% Diluted EPS, excluding charges & credits* $0.35 $0.30 $0.43 17% -19% North America revenue $2,801 $2,738 $3,139 2% -11% International revenue $5,463 $5,037 $5,065 8% 8% North America revenue, excluding Cameron $2,243 $2,178 $2,546 3% -12% International revenue, excluding Cameron $4,761 $4,469 $4,387 7% 9% *These are non-GAAP financial measures. See section titled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commente

Schlumberger Appoints Olivier Le Peuch as CEO19.7.2019 13:46:00 EESTPress release

Schlumberger Limited (NYSE: SLB) announced today that its Board of Directors has appointed Olivier Le Peuch as its Chief Executive Officer and member of the Schlumberger Board, effective August 1, 2019. Mr. Le Peuch succeeds Paal Kibsgaard, who will retire as Chief Executive Officer effective that same date. Also effective August 1, Mr. Kibsgaard will step down as Chairman of the Board and retire as a member of the Board of Directors. Mr. Kibsgaard will retire after more than 22 years of service to the Company, including eight years as CEO and four years as Chairman. Effective the same date, Mark G. Papa, a current non-independent director, will become non-executive Chairman of the Board. Peter Currie will continue to serve as the Board’s Lead Independent Director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190719005161/en/ Olivier Le Peuch is appointed Chief Executive Officer and a member of the Schlumberger Board, effe

Fluke Corporation Acquires Industrial Reliability Leader PRÜFTECHNIK19.7.2019 13:00:00 EESTPress release

Fluke Corp., the global leader in test and measurement instruments, has acquired Ismaning, Germany-based PRÜFTECHNIK, a market leader in precision laser shaft alignment, condition monitoring, and non-destructive testing. “Fluke’s acquisition of PRÜFTECHNIK reflects the growing importance our customers place on reliability systems to keep their equipment in optimum operating condition,” said Marc Tremblay, president of Fluke Corporation. “This business will help us usher in the next generation of solutions for our industrial customers.” Fluke Corporation For information on Fluke tools and applications, or to find the location of your nearest distributor, contact Fluke Corporation, P.O. Box 9090, Everett, WA USA 98206, call (800) 44-FLUKE (800-443-5853), fax (425) 446-5116, e-mail fluke-info@fluke.com or visit the Fluke Web site at http://www.fluke.com. About Fluke Founded in 1948, Fluke Corporation is the world leader in compact, professional electronic test tools and software for measu

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom